Genomic Testing Should Be a First-Line Tool in Modern Healthcare, Experts Say

Genomic Testing Remains Underutilized Despite Its Potential

For decades, genetic testing has been viewed as a rare and highly specialized tool, reserved for the end of a prolonged diagnostic journey and accessible only to geneticists. While medicine has evolved with scientific and technological advancements, the practical application of genomic testing has lagged behind. Exome and genome sequencing should no longer be treated as exceptional services but as essential components of everyday clinical care.

The insights encoded in human DNA are foundational to understanding health and disease. Yet, genomic testing is often considered a last resort rather than an initial step in diagnosis. To improve patient care, the healthcare system must rethink the role of genomic testing in modern medicine.

Patients Demand a Proactive, Molecular Approach to Health

Across the healthcare landscape, individuals are increasingly seeking deeper biological insights. A new wave of companies, such as Function Health and Prenuvo, is gaining popularity by offering consumers a comprehensive, molecular perspective on their health. These companies address a gap in traditional healthcare by providing proactive insights that help people understand their bodies before issues escalate.

This shift reflects a broader transformation in healthcare expectations. Patients no longer want a system that merely reacts to disease; they want one that anticipates and prevents it. Genomics is central to this future, offering the data needed to identify risks and tailor care accordingly.

The Clinical Benefits of Genomic Insights

DNA holds critical information about why diseases occur and how they can be treated. For children with neurological conditions, developmental delays, or unexplained medical challenges, genomic testing can uncover the root cause of illness. Identifying a genetic diagnosis can:

• Enable more targeted treatments;
• Reduce unnecessary diagnostic tests;
• Provide families with clearer answers and guidance;
• Improve efficiency and cost savings within the healthcare system.

For many patients, genomic testing ends the so-called “diagnostic odyssey”—years spent searching for answers without resolution. However, the value of genomic insight is realized only when it is applied in practice.

Why Genomic Testing Remains Underused

Despite its growing impact, genomic testing is still underutilized. The primary barrier is cultural, not scientific. Historically, genetic testing has been associated with specialists, leading many frontline clinicians to view it as outside their scope of practice. A persistent misconception is that genomic testing requires a genetics expert or should only be ordered after other diagnostic options have been exhausted.

In reality, many clinicians—including pediatricians, neurologists, and neonatal intensive care physicians—already have the authority to order genomic tests. Clinical guidelines in many cases recommend exome or genome sequencing as a first-line diagnostic tool. Yet, outdated perceptions continue to limit its use.

Breaking Down Barriers to Adoption

To fully integrate genomic testing into routine care, healthcare systems must address these cultural and educational gaps. Clinicians need better training and resources to understand when and how to incorporate genomic testing into their practice. Additionally, patients must be empowered to advocate for molecular insights as part of their care journey.

The future of healthcare lies in proactive, data-driven medicine. Genomic testing is not just an advanced tool for specialists—it is a foundational resource for all clinicians and patients seeking to understand and improve health outcomes.